z-logo
open-access-imgOpen Access
Possibilities of radionuclide visualization of HER2/neu-positive breast cancer using a radiopharmaceutical based on recombinant targeting molecules DARPin9_29
Author(s) -
Olga Bragina,
В. И. Чернов,
А. A. Medvedeva,
Roman Zelchan,
Sergey M. Deyev,
Vladimir Tolmachev
Publication year - 2020
Publication title -
сибирский научный медицинский журнал
Language(s) - English
Resource type - Journals
eISSN - 2410-2520
pISSN - 2410-2512
DOI - 10.15372/ssmj20200405
Subject(s) - her2/neu , recombinant dna , breast cancer , medicine , cancer research , radionuclide , radionuclide therapy , oncology , cancer , nuclear medicine , pathology , chemistry , biochemistry , physics , gene , quantum mechanics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom